沙美特罗替卡松气雾剂联合无创通气治疗老年慢性阻塞性肺疾病患者的疗效分析

摘要

目的：沙美特罗替卡松气雾剂（舒利迭）联合无创通气治疗老年慢性阻塞性肺疾病（COPD）呼吸衰竭的临床疗效。方法：本院收治的120例患者老年COPD患者，分为两组，对照组采取常规治疗+无创通气治疗，观察组采取常规治疗+无创通气治疗+舒利迭治疗，比较两组治疗前后各项指标。结果：观察组治疗后的心率、呼吸频率均显著低于对照组（均P＜0.05）；观察组治疗后的氧分压，显著高于对照组，而二氧化碳分压，显著低于对照组（均P＜0.05）；观察组治疗后的FEV1，FEV1/FVC，FEV1%预测值，均显著高于对照组（均P＜0.05）。结论：舒利迭联合无创通气治疗老年COPD呼吸衰竭患者的效果显著，可以促进患者肺功能的恢复，稳定患者的病情。%Objective: Clinical efficacy of Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation(Seretide)take joint noninvasive ventilation therapy in elderly COPD patients with respiratory failure. Methods:The group of 120 patients were admitted to the Central Hospital of People's Liberation Army 169 elderly COPD patients, divided into two groups, the control group received conventional therapy plus noninvasive ventilation treatment, observation group received conventional therapy plus noninvasive ventilation + Seretide, indicators were compared before and after treatment.Results: Heart rate in observation group after treatment, respiratory rate were significantly lower than the control group (P<0.05); partial pressure of oxygen in the observation group after treatment was significantly higher, while the carbon dioxide partial pressure, was significantly lower than the control group (P<0.05); FEV1 observation group after treatment, FEV1 / FVC, FEV1% predicted values were significantly higher (P<0.05). Conclusion: Seretide joint noninvasive ventilation for aged patients with chronic obstructive pulmonary disease and respiratory failure in patients with significant effect, promoting the recovery of pulmonary function, the patient's condition stable.